146 related articles for article (PubMed ID: 24418212)
1. Different affinity of nuclear factor-kappa B proteins to DNA modified by antitumor cisplatin and its clinically ineffective trans isomer.
Kasparkova J; Thibault T; Kostrhunova H; Stepankova J; Vojtiskova M; Muchova T; Midoux P; Malinge JM; Brabec V
FEBS J; 2014 Mar; 281(5):1393-1408. PubMed ID: 24418212
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of nuclear factor kappaB proteins-platinated DNA interactions correlates with cytotoxic effectiveness of the platinum complexes.
Brabec V; Kasparkova J; Kostrhunova H; Farrell NP
Sci Rep; 2016 Aug; 6():28474. PubMed ID: 27574114
[TBL] [Abstract][Full Text] [Related]
3. Different recognition of DNA modified by aatitumor cisplatin and its clinically ineffective trans isomer by tumor suppressor protein p53.
Kasparkova J; Pospisilova S; Brabec V
J Biol Chem; 2001 May; 276(19):16064-9. PubMed ID: 11279186
[TBL] [Abstract][Full Text] [Related]
4. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
Kasparkova J; Novakova O; Farrell N; Brabec V
Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
[TBL] [Abstract][Full Text] [Related]
5. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
[TBL] [Abstract][Full Text] [Related]
6. Transplatin enhances effect of cisplatin on both single DNA molecules and live tumor cells.
Liu YR; Ji C; Zhang HY; Dou SX; Xie P; Wang WC; Wang PY
Arch Biochem Biophys; 2013 Aug; 536(1):12-24. PubMed ID: 23664917
[TBL] [Abstract][Full Text] [Related]
7. Cellular pharmacology of cis and trans pairs of platinum complexes in cisplatin-sensitive and -resistant human ovarian carcinoma cells.
O'Neill CF; Hunakova L; Kelland LR
Chem Biol Interact; 1999 Nov; 123(1):11-29. PubMed ID: 10597899
[TBL] [Abstract][Full Text] [Related]
8. Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin.
Kasparkova J; Fojta M; Farrell N; Brabec V
Nucleic Acids Res; 2004; 32(18):5546-52. PubMed ID: 15486204
[TBL] [Abstract][Full Text] [Related]
9. Ginkgolide B enhances gemcitabine sensitivity in pancreatic cancer cell lines via inhibiting PAFR/NF-кB pathway.
Lou C; Lu H; Ma Z; Liu C; Zhang Y
Biomed Pharmacother; 2019 Jan; 109():563-572. PubMed ID: 30399592
[TBL] [Abstract][Full Text] [Related]
10. Activation of trans geometry in bifunctional mononuclear platinum complexes by a non-bulky methylamine ligand.
Frybortova M; Novakova O; Stepankova J; Novohradsky V; Gibson D; Kasparkova J; Brabec V
J Inorg Biochem; 2013 Sep; 126():46-54. PubMed ID: 23770803
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin.
Trimmer EE; Essigmann JM
Essays Biochem; 1999; 34():191-211. PubMed ID: 10730196
[TBL] [Abstract][Full Text] [Related]
12. Chemical versatility of transplatin monofunctional adducts within multiple site-specifically platinated DNA.
Bernal-Méndez E; Boudvillain M; González-Vilchez F; Leng M
Biochemistry; 1997 Jun; 36(24):7281-7. PubMed ID: 9200676
[TBL] [Abstract][Full Text] [Related]
13. DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes.
Novakova O; Kasparkova J; Malina J; Natile G; Brabec V
Nucleic Acids Res; 2003 Nov; 31(22):6450-60. PubMed ID: 14602903
[TBL] [Abstract][Full Text] [Related]
14. The induction of lysis in lysogenic strains of Escherichia coli by a new antitumor transplatin derivative and its DNA interactions.
Brabec V; Pracharova J; Novakova O; Gibson D; Kasparkova J
Dalton Trans; 2015 Feb; 44(8):3573-82. PubMed ID: 25406573
[TBL] [Abstract][Full Text] [Related]
15. Energetics, conformation, and recognition of DNA duplexes containing a major adduct of an anticancer azolato-bridged dinuclear Pt(II) complex.
Mlcouskova J; Malina J; Novohradsky V; Kasparkova J; Komeda S; Brabec V
Biochim Biophys Acta; 2012 Oct; 1820(10):1502-11. PubMed ID: 22683702
[TBL] [Abstract][Full Text] [Related]
16. Monofunctional platinum-DNA adducts are strong inhibitors of transcription and substrates for nucleotide excision repair in live mammalian cells.
Zhu G; Myint M; Ang WH; Song L; Lippard SJ
Cancer Res; 2012 Feb; 72(3):790-800. PubMed ID: 22180496
[TBL] [Abstract][Full Text] [Related]
17. Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-кB target genes in human breast cancer.
Dalmases A; González I; Menendez S; Arpí O; Corominas JM; Servitja S; Tusquets I; Chamizo C; Rincón R; Espinosa L; Bigas A; Eroles P; Furriol J; Lluch A; Rovira A; Albanell J; Rojo F
Oncotarget; 2014 Jan; 5(1):196-210. PubMed ID: 24344116
[TBL] [Abstract][Full Text] [Related]
18. Differential activation of NF-κB signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells.
Gaikwad SM; Thakur B; Sakpal A; Singh RK; Ray P
Int J Biochem Cell Biol; 2015 Apr; 61():90-102. PubMed ID: 25681684
[TBL] [Abstract][Full Text] [Related]
19. MiR-20a lowers chemosensitivity of liver cancer Huh-7 cells via regulating NF-кB expression.
Yang BM; Zhao JR; Huo TT; Zhang ML; Wu XH
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11569-11577. PubMed ID: 33275223
[TBL] [Abstract][Full Text] [Related]
20. Increased nuclear expression of nuclear factor kappa-B p65 subunit in the eutopic endometrium and ovarian endometrioma of women with advanced stage endometriosis.
Kim SH; Ihm HJ; Oh YS; Chae HD; Kim CH; Kang BM
Am J Reprod Immunol; 2013 Dec; 70(6):497-508. PubMed ID: 24118362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
